Successful treatment of monoclonal, aggressive Epstein-Barr virus- associated B-cell lymphoproliferative disorder in a child with acute lymphoblastic leukemia

Medical and Pediatric Oncology

Volumn 32, Issue 6, 1999, Pages 447-449

  Perkkiö, Mikko ^a   Riikonen, Pekka ^a   Seuri, Raija ^a   Vornanen, Martine ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Acute lymphoblastic leukemia; Child; Cyclophosphamide; Epstein Barr virus; Lymphoproliferative disorder

Indexed keywords

CYCLOPHOSPHAMIDE; HEMOPOIETIC GROWTH FACTOR; MERCAPTOPURINE; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; EPSTEIN BARR VIRUS; HUMAN; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

6-MERCAPTOPURINE; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; CHILD; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LUNG NEOPLASMS; LYMPHOMA, B-CELL; MALE; METHOTREXATE; TREATMENT OUTCOME;

EID: 0033008019     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199906)32:6<447::AID-MPO12>3.0.CO;2-1     Document Type: Article

References (8)

1. Seibel NL, Cossman J, Magrath IT. Lymphoproliferative disorders. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 2nd ed. Philadelphia: Lippincott; 1993. p 595-616.
2. Look AT, Naegele RF, Callihan T, et al. Fatal Epstein-Barr virus infection in a child with acute lymphoblastic leukemia in remission. Cancer Res 1981;41:4280-4283.
3. Hardy C, Feusner J, Harada S, et al. Fatal Epstein-Barr virus-induced lymphoproliferation complicating acute lymphoblastic leukemia. J Pediatr 1984;105:64-67.
4. Joncas JH, Russo P, Brochu P, et al. Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies. J Clin Oncol 1990;8:378-384.
5. Mustafa MM, Winick NJ, Margraf LR. Epstein-Barr virus lymphoproliferative disorder in children with leukemia: case report and review of the literature. J Pediatr Hematol Oncol 1997;19: 77-81.
6. Jack AS, Johnson R, Morgan GJ. The detection and clinical significance of monoclonality in lymphoproliferative disorders. Curr Diagn Pathol 1995;2:181-194.
7. Knowles DM, Cesarman E. Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995;85:552-565.
8. Fischer A, Blanche S, Bidois JL, et al. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 1991;324:1451-1456.